Application Segmentation The application segmentation of the Tubular Anorectal Stapler market is driven primarily by three surgical procedures: low anterior resection (LAR), abdominoperineal resection (APR), and transanal endoscopic microsurgery (TEM). LAR accounts for roughly 55 % of total unit sales, reflecting its prevalence in rectal cancer treatment and the stapler’s role in restoring bowel continuity. APR, representing about 30 % of the market, utilizes the device for permanent colostomy creation, where the stapler’s reliability in transecting the distal rectum is critical. TEM, a minimally invasive approach, contributes the remaining 15 % and is expanding as clinicians adopt sphincter‑preserving techniques. The relative weight of each application directly influences revenue distribution, as LAR‑linked procedures command higher price points due to larger device sizes and ancillary consumables. Consequently, the aggregate market size is a weighted sum of these application shares, with LAR driving the bulk of growth in the Tubular Anorectal Stapler segmentation. Future shifts toward organ‑preserving protocols may modestly increase the TEM proportion, subtly reshaping the market composition.